CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 53 filers reported holding CATALYST BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16 | +33.3% | 34,165 | 0.0% | 0.01% | +33.3% |
| Q2 2023 | $12 | +71.4% | 34,165 | 0.0% | 0.01% | +80.0% |
| Q1 2023 | $7 | -61.1% | 34,165 | 0.0% | 0.01% | -66.7% |
| Q4 2022 | $18 | -99.7% | 34,165 | +149.2% | 0.02% | +150.0% |
| Q3 2022 | $7,000 | -70.8% | 13,712 | 0.0% | 0.01% | -68.4% |
| Q2 2022 | $24,000 | +166.7% | 13,712 | 0.0% | 0.02% | +216.7% |
| Q1 2022 | $9,000 | -25.0% | 13,712 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $12,000 | -78.6% | 13,712 | 0.0% | 0.01% | -80.0% |
| Q3 2021 | $56,000 | -5.1% | 13,712 | 0.0% | 0.04% | 0.0% |
| Q2 2021 | $59,000 | -14.5% | 13,712 | 0.0% | 0.04% | -18.4% |
| Q1 2021 | $69,000 | -20.7% | 13,712 | 0.0% | 0.05% | -22.2% |
| Q4 2020 | $87,000 | +47.5% | 13,712 | 0.0% | 0.06% | +28.6% |
| Q3 2020 | $59,000 | -26.2% | 13,712 | 0.0% | 0.05% | -30.0% |
| Q2 2020 | $80,000 | +35.6% | 13,712 | 0.0% | 0.07% | +27.3% |
| Q1 2020 | $59,000 | – | 13,712 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,076,376 | $13,321,000 | 6.97% |
| 22NW, LP | 1,429,242 | $6,189,000 | 1.66% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,330,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 685,000 | $2,966,000 | 1.18% |
| Sio Capital Management, LLC | 623,892 | $2,701,000 | 0.67% |
| Parkman Healthcare Partners LLC | 393,449 | $1,704,000 | 0.37% |
| Nantahala Capital Management | 2,531,360 | $10,961,000 | 0.31% |
| AlphaCentric Advisors LLC | 182,500 | $790,000 | 0.22% |
| Ikarian Capital, LLC | 581,200 | $2,518,000 | 0.20% |
| Tibra Equities Europe Ltd | 79,200 | $343,000 | 0.11% |